UY29441A1 - Oblea que contiene hormonas esteroides - Google Patents

Oblea que contiene hormonas esteroides

Info

Publication number
UY29441A1
UY29441A1 UY29441A UY29441A UY29441A1 UY 29441 A1 UY29441 A1 UY 29441A1 UY 29441 A UY29441 A UY 29441A UY 29441 A UY29441 A UY 29441A UY 29441 A1 UY29441 A1 UY 29441A1
Authority
UY
Uruguay
Prior art keywords
steroid hormones
oblea
application system
film
containing steroid
Prior art date
Application number
UY29441A
Other languages
English (en)
Spanish (es)
Inventor
Markus Krume
Sascha General
Albert Radlmaier
Michael Dittgen
Keith Jensen
Original Assignee
Lts Lohmann Therapie Sisteme A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36998911&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29441(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lts Lohmann Therapie Sisteme A filed Critical Lts Lohmann Therapie Sisteme A
Publication of UY29441A1 publication Critical patent/UY29441A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UY29441A 2005-03-31 2006-03-27 Oblea que contiene hormonas esteroides UY29441A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005015128A DE102005015128B4 (de) 2005-03-31 2005-03-31 Wafer enthaltend Steroidhormone

Publications (1)

Publication Number Publication Date
UY29441A1 true UY29441A1 (es) 2006-10-31

Family

ID=36998911

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29441A UY29441A1 (es) 2005-03-31 2006-03-27 Oblea que contiene hormonas esteroides

Country Status (26)

Country Link
US (2) US9763960B2 (https=)
EP (1) EP1863444B1 (https=)
JP (2) JP5843416B2 (https=)
KR (2) KR20140063740A (https=)
CN (2) CN101132766A (https=)
AR (1) AR054245A1 (https=)
AU (1) AU2006228820B2 (https=)
BR (1) BRPI0609601A2 (https=)
CA (1) CA2598892C (https=)
CR (1) CR9468A (https=)
DE (1) DE102005015128B4 (https=)
DO (1) DOP2006000070A (https=)
EA (1) EA014183B1 (https=)
GT (1) GT200600126A (https=)
IL (1) IL186081A0 (https=)
MX (1) MX2007012081A (https=)
NO (1) NO20075404L (https=)
NZ (1) NZ592882A (https=)
PE (1) PE20061194A1 (https=)
SG (1) SG179459A1 (https=)
SV (1) SV2008002466A (https=)
TW (1) TWI393576B (https=)
UA (1) UA92011C2 (https=)
UY (1) UY29441A1 (https=)
WO (1) WO2006102990A2 (https=)
ZA (1) ZA200706116B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2604943C (en) 2005-04-15 2013-09-17 Clarus Therapeutics, Inc. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
DE102006027796A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Estrogen-Gestagen-Kombinationen
NZ586666A (en) * 2008-02-13 2012-04-27 Bayer Schering Pharma Ag Estradiol-containing drug delivery system
EA018330B1 (ru) * 2008-02-13 2013-07-30 Байер Интеллекчуал Проперти Гмбх Система доставки лекарственного средства со стабилизирующим эффектом
TW201008569A (en) * 2008-08-08 2010-03-01 Bayer Schering Pharma Ag Progestin-containing drug delivery system
WO2010057594A1 (en) * 2008-11-21 2010-05-27 Bayer Schering Pharma Aktiengesellschaft Drug delivery system
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
DK3254676T3 (en) 2009-10-30 2019-03-11 Ix Biopharma Ltd QUICK-SOLVING SOLID DOSAGE FORM
US10806703B2 (en) * 2012-01-20 2020-10-20 Lts Lohmann Therapie-System Ag Transmucosal administration system for a pharmaceutical drug
EP2874824B1 (en) 2012-07-23 2025-04-30 Crayola, LLC Dissolvable films and methods of using the same
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
AU2019215163A1 (en) * 2018-02-02 2020-08-20 Acerus Biopharma Inc. Methods of testosterone therapy
US11564933B2 (en) 2019-04-12 2023-01-31 Tolmar, Inc. Methods of treating testosterone deficiency

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB981372A (en) * 1960-05-04 1965-01-27 Pfizer Ltd Pharmaceutical formulations for oral administration to animals
US4136162A (en) 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
ES2105262T3 (es) * 1992-05-18 1997-10-16 Minnesota Mining & Mfg Dispositivo de suministro de farmaco a traves de las mucosas.
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
DE19847252B4 (de) * 1998-10-02 2004-02-12 Jenapharm Gmbh & Co. Kg Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030092658A1 (en) * 2001-02-02 2003-05-15 Meyers Rachel E. Novel human enzyme family members and uses thereof
WO2002003965A1 (en) * 2000-07-06 2002-01-17 Delsys Pharmaceutical Corporation Method for formulating healthcare products with enhanced stability
GB0100760D0 (en) * 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
FR2832311B1 (fr) * 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
JO2492B1 (en) * 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
JP2007500729A (ja) * 2003-07-31 2007-01-18 アイバックス コーポレイション 雄性及び雌性の性機能障害の治療方法
DK1670433T3 (da) * 2003-10-10 2012-03-12 Ferring Bv Transdermal farmaceutisk formulering til mindskelse af hudrester

Also Published As

Publication number Publication date
EA014183B1 (ru) 2010-10-29
EP1863444B1 (de) 2015-12-09
JP5843416B2 (ja) 2016-01-13
AU2006228820B2 (en) 2011-08-25
EA200702102A1 (ru) 2008-04-28
US9763960B2 (en) 2017-09-19
AU2006228820A1 (en) 2006-10-05
CA2598892C (en) 2014-10-14
US20060222708A1 (en) 2006-10-05
KR101428625B1 (ko) 2014-08-13
JP2013155190A (ja) 2013-08-15
WO2006102990A3 (de) 2007-03-22
PE20061194A1 (es) 2006-11-23
UA92011C2 (ru) 2010-09-27
NZ592882A (en) 2012-12-21
KR20080002798A (ko) 2008-01-04
ZA200706116B (en) 2008-11-26
CN104983669B (zh) 2018-05-18
DOP2006000070A (es) 2007-08-15
DE102005015128B4 (de) 2008-12-11
US20170348321A1 (en) 2017-12-07
MX2007012081A (es) 2007-11-21
GT200600126A (es) 2007-03-14
CN101132766A (zh) 2008-02-27
SG179459A1 (en) 2012-04-27
KR20140063740A (ko) 2014-05-27
SV2008002466A (es) 2008-02-08
CA2598892A1 (en) 2006-10-05
AR054245A1 (es) 2007-06-13
TW200714299A (en) 2007-04-16
JP2008534533A (ja) 2008-08-28
EP1863444A2 (de) 2007-12-12
BRPI0609601A2 (pt) 2010-04-20
DE102005015128A1 (de) 2006-10-05
WO2006102990A2 (de) 2006-10-05
CN104983669A (zh) 2015-10-21
TWI393576B (zh) 2013-04-21
IL186081A0 (en) 2008-01-20
NO20075404L (no) 2007-12-20
CR9468A (es) 2008-01-21

Similar Documents

Publication Publication Date Title
UY29441A1 (es) Oblea que contiene hormonas esteroides
AR060306A1 (es) Terapia de combinacion de anticuerpos contra ctla4
AR049985A1 (es) Tratamiento de combinacion para enfermedades malignas no hematologicas
AR068185A1 (es) Composiciones de tabletas de desintegracion oral de lamotrigina
AR065246A1 (es) Composiciones para mejorar la absorcion gastrointestinal de nutrientes y de farmacos
AR033418A1 (es) Preparado farmaceutico mucoadhesivo desintegrable para la administracion de sustancia activa en medicina veterinaria y humana
CO6670567A2 (es) Métodos de tratamiento contra el cáncer pancreático
PH12015500407B1 (en) Methods of treating hypertriglyceridemia
EA200870219A1 (ru) Стабилизированные сукцинатом витамина е фармацевтические композиции, способы их получения и применения
GT201000182A (es) Regimen de dosificacion asociado con ésteres de paliperidona inyectables de acción prolongada
SV2011003828A (es) Anticuerpos monoclonales contra el inhibidor de la via del factor tisular (tfpi)
BR112013027674A2 (pt) "usos de composições de nanopartículas, composições compreendendo as referidas nanopartículas e cateter com uma agulha".
UY32926A (es) Compuestos como antagonistas de los receptores de ácido lisofosfatídico
AR060836A1 (es) Un disco trans-mucosa para administrar un agente activo, una composicion trans-mucosa y el metodo de administracion obtenido
BR112014011841A2 (pt) material de entrega de fármacos hidrofóbicos, método para a produção do mesmo e métodos para a entrega de uma composição de entrega de fármacos
EA201001287A1 (ru) Лечение гиперглицемии 25-гидроксивитамином d3
EA201001288A1 (ru) Лечение гипертонии 25-гидроксивитамином d3
UY32821A (es) Cápsulas de liberación sostenida
DE602008006700D1 (https=)
AR057946A1 (es) Formulacion de zonisamida de liberacion sostenidda
ECSP14023048A (es) Agentes terapéuticos para administración subcutánea optimizados
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
PE20081573A1 (es) Composiciones y metodos para tratar las convulsiones
BR112012014107B8 (pt) sistema terapêutico transdérmico (tts) e processo de produção de tts
AR059577A1 (es) Agente de aceleracion de absorcion del calcio

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160810